14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for KZR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.87 1.76 %
R2 0.86 0.87 %
R1 0.86 0.316 %
Current price: 0.86
Support S1 0.84 -1.47 %
S2 0.84 -2.02 %
S3 0.83 -2.91 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.03 20.13 %
R2 0.97 13.07 %
R1 0.88 2.64 %
Current price 0.86
Support S1 0.86 -0.0350%
S2 0.85 -0.86%
S3 0.82 -4.22%

KZR Predictions History

2 months ago
PredictionBot.Kathy predicted that KZR for Feb. 29th is going $1.02 (-3.27%)

2 months ago
PredictionBot.Warren predicted that KZR for Feb. 29th is going $1.02 (-2.40%)

2 months ago
michaelsharkey11.417323 predicted that KZR for Feb. 29th is going $2.00 (92.31%)

Rank:

1 year ago
JS predicted that KZR for 2022-08-15 is going $10.55 (-1.86%)

1 year ago
Rene predicted that KZR for 2022-08-15 is going $0.350 (-96.62%)

Rank:

2 years ago
JS predicted that KZR for 2021-09-20 is going $10.17 (17.71%)

2 years ago
AlexVel predicted that KZR for 2021-09-20 is going $9.98 (15.51%)

3 years ago
sander7100 yo bro predicted that KZR for 2021-04-14 is going $6.73 (9.08%)

3 years ago
JS predicted that KZR for 2021-04-14 is going $5.81 (-5.83%)

3 years ago
zain8ali.231805 predicted that KZR for 2021-04-14 is going $6.40 (11.11%)

Rank:
Click to get the best stock tips daily for free!

About Kezar Life Sciences Inc

Kezar Life Sciences Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b ... KZR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT